Answer
Sunitinib can impair healing and has been associated with osteonecrosis of the jaw, especially with intravenous bisphosphonates. Dental procedures should be coordinated with the oncology team.
Sources for this answer
- Sunitinib Mylan 50 mg Hard Capsules — Current selected SmPCemc · Summary of Product Characteristics
- UK GovernmentUK Government · Reputable Web
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.